Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-041919
Filing Date
2021-02-12
Accepted
2021-02-12 17:19:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d334471dsc13g.htm SC 13G 35513
  Complete submission text file 0001193125-21-041919.txt   36765
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address
Ackermann Michael (Filed by) CIK: 0001791249 (see all company filings)

Type: SC 13G

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91774 | Film No.: 21629728
SIC: 2836 Biological Products, (No Diagnostic Substances)